跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
TGA
/
AMOXYCLAV B&B 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack
Approved
STANDARD
AMOXYCLAV B&B 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack
Micro Labs Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 30, 2025
Approval ID
0a16cb3746dde32a
Company
Micro Labs Pty Ltd
Type
Standard
Approval Details
Approval Id
0a16cb3746dde32a
Product Name
AMOXYCLAV B&B 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack
Artg Id
236904
Artg Name
AMOXYCLAV B&B 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack
Sponsor
Micro Labs Pty Ltd
Company Detail Path
/organization/micro-labs-pty-ltd
Artg Date
2016-04-07
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 30, 2025
Approval ID
0a16cb3746dde32a
Type
Standard
Back to TGA Approvals
AMOXYCLAV B&B 875/125, amoxicillin (as trihydrate) 875 mg and clavulanic acid (as potassium) 125 mg tablets strip pack - TGA Drug Approval Details
